Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective Study

Overview of attention for article published in Drugs in R&D, September 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 7,403 followers.

RT @IKCCORG: Sounds reasonable. Would be great to see a larger sample size @ANZUPtrials @DrCraigGedye #sunitinib #kidneycancer https://t.co…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.